Grand Rapids Business Journal -- Login

Teamwork Produces New Test
Testing a patient’s blood will determine the severity of side effects to be expected during radiation therapy treatments, so alternate treatments may be considered.
Anne Bond Emrich
Published: January 24, 2008
GRAND RAPIDS — Through a collaboration with the West Michigan Center for Family Health, the Van Andel Research Institute has come up with a simple blood test that can predict how well a cancer patient is going to tolerate radiation therapy.

Complete article text is available only to SUBSCRIBERS.

Subscribing to Grand Rapids Business Journal Express also subscribes you to the print version of the journal at no additional cost.

Customer ID

E-Mail Address

Forgot your login information?

Not A Subscriber? Here are your options!

Subscription Options

New Subscriber
If you are not a current subscriber to the Grand Rapids Business Journal, use this option. By subscribing to the website, you will also receive the print version of the Grand Rapids Business Journal at no additional cost.

Existing Subscriber
If you currently receive the print version of Grand Rapids Business Journal and would like to sign up for your free online subscription to the Grand Rapids Business Journal Express, use this option.

One-time View Subscription
If you would like to purchase the right to view the full text of this article without purchasing a subscription to the Grand Rapids Business Journal, use this option.